VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 75 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,082,609 | +45.1% | 94,551 | -2.3% | 0.02% | +25.0% |
| Q1 2023 | $746,151 | +76.5% | 96,777 | +39.6% | 0.01% | +50.0% |
| Q4 2022 | $422,815 | -4.3% | 69,314 | -7.1% | 0.01% | 0.0% |
| Q3 2022 | $442,000 | +30.8% | 74,607 | +30.4% | 0.01% | +33.3% |
| Q2 2022 | $338,000 | +2153.3% | 57,213 | +6423.7% | 0.01% | – |
| Q4 2017 | $15,000 | -67.4% | 877 | -60.4% | 0.00% | -100.0% |
| Q3 2017 | $46,000 | – | 2,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |